A Two-Dimensional Approach to Study Amyloid β-Peptide Fragment (25−35)
Source abstract
Abstract
The neuritic plaques formed by amyloid β-peptide (Aβ) play a seminal role in the pathogenesis of Alzheimer's disease (AD). Aβ sequence 25−35 (GSNKGAIIGLM) is among the most frequently studied Aβ derivatives for the reason that it possesses the structural characteristic of Aβ and remains neurotoxic. Aβ(25−35) was modified with an aliphatic chain (C 18 ) at the N-terminal of the peptide for the study of the Langmuir monolayer at the air−water interface. The main advantage of the 2D approach is the self-assembly of the peptide moiety in the subphase, and therefore the aggregation process of the peptidolipid Aβ(25−35) was monitored by surface pressure and surface potential−area isotherms. The real-time epifluorescence microscopy was utilized to observe the topography of the domains formed, whereas polarization modulation infrared reflection absorption spectroscopy (PM-IRRAS) provided the information on the structural features of the domains at the air−water interface. Langmuir−Blodgett films were prepared to examine by circular dichroism (CD) the conformation of the peptidolipid film in the domains.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Supramolecular Self-Assembly in Materials · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Miami, 1301 Memorial Drive, Coral Gables, Florida 33146
References (21)
Show source-provided references
1. Selkoe D. · J. Nature · 1999 · 399 · A2310.1038/399a023 ↗
2. Terry R. D. · Prog. Brain Res. · 1994 · 101 · 38310.1016/S0079-6123(08)61964-0 ↗
3. Selkoe D. · J. Trends Cell Biol. · 1998 · 8 · 44710.1016/S0962-8924(98)01363-4 ↗
4. Masters C. L. · Proc. Natl. Acad. Sci. U.S.A. · 1985 · 82 · 424510.1073/pnas.82.12.4245 ↗
5. Noda-Saita K. · Neuroscience · 2006 · 138 · 120510.1016/j.neuroscience.2005.12.036 ↗
6. Iverson L. L. · Biochem. J. · 1995 · 311 · 110.1042/bj3110001 ↗
7. Bateman R. J. · Nat. Med. · 2006 · 12 · 85610.1038/nm1438 ↗
8. Haglund M. · Acta Neuropathol. · 2006 · 111 · 43010.1007/s00401-006-0054-z ↗
9. Benzinger T. L. S. · Biochemistry · 2000 · 39 · 349110.1021/bi991527v ↗
10. Terzi E. · Biochemistry · 1994 · 33 · 134510.1021/bi00172a009 ↗
11. Cheng G. · Neurobiol. Dis. · 2006 · 23 · 14010.1016/j.nbd.2006.02.008 ↗
12. Pike C. J. · J. Neurosci. · 1993 · 13 · 167610.1523/JNEUROSCI.13-04-01676.1993 ↗
13. Li C. · Langmuir · 2004 · 20 · 864110.1021/la0490339 ↗
14. Hiramatsu H. · Biochim. Biophys. Acta · 2005 · 1753 · 10010.1016/j.bbapap.2005.07.008 ↗
15. Martin A. H. · 2003
16. Walton, A. G.; Blackwell, J.Biopolymers; Academic Press Inc. New York, 1973; Chapter 6.
17. Fasman G. D. · Biochem. Biophys. Res. Commun. · 1967 · 27 · 20910.1016/S0006-291X(67)80063-9 ↗
18. Rippon W. B. · J. Mol. Biol. · 1973 · 75 · 36910.1016/0022-2836(73)90027-2 ↗
19. Goodman, M.; Toniolo, C.; Naider, F. InPeptides, Polypeptides andProteins; Blout, E. R., Bovey, F. A., Goodman, M., Lotan, N., Eds.; Wiley: New York, 1974; p 308.
20. Goodman M. · Proc. Natl. Acad. Sci. U.S.A. · 1969 · 64 · 44410.1073/pnas.64.2.444 ↗
21. Takano K. · FEBS J. · 2006 · 273 · 15010.1111/j.1742-4658.2005.05051.x ↗